Biomarkers and cardiovascular risk assessment for primary prevention: an update
- PMID: 22125305
- PMCID: PMC4105324
- DOI: 10.1373/clinchem.2011.165712
Biomarkers and cardiovascular risk assessment for primary prevention: an update
Abstract
Background: Interest in cardiovascular biomarkers in primary prevention has increased dramatically in the past decade. This increase has been fueled by an improved understanding of cardiovascular pathophysiology, as well as novel technologies for biomarker identification.
Content: In this review we provide a brief overview of recent concepts in the evaluation of screening biomarkers, because biomarkers may behave differently when used for screening as opposed to diagnosis or disease staging. The following specific biomarker examples are then discussed, with a focus on data from primary prevention studies: high-sensitivity C-reactive protein, B-type natriuretic peptide, lipoprotein-associated phospholipase A2, and high-sensitivity troponin T. The article concludes by addressing novel platforms for biomarker discovery, reviewing recent examples from the field of metabolomics.
Summary: An ongoing challenge is to develop screening strategies that can identify individuals at risk for cardiovascular events well before symptoms appear. For this purpose, the measurement of soluble biomarkers could be an important adjunct to traditional cardiovascular risk assessment. Recent studies highlight both the strengths and limitations of "novel" circulating biomarkers, and suggest that substantial work is still needed to identify biomarkers that are sufficiently accurate and cost-effective for routine use in primary prevention.
Figures
Similar articles
-
Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study.Atherosclerosis. 2016 Oct;253:156-163. doi: 10.1016/j.atherosclerosis.2016.08.028. Epub 2016 Aug 25. Atherosclerosis. 2016. PMID: 27665201 Free PMC article.
-
Circulating troponin as measured by a sensitive assay for cardiovascular risk assessment in primary prevention.Clin Chem. 2012 Jan;58(1):200-8. doi: 10.1373/clinchem.2011.174292. Epub 2011 Dec 7. Clin Chem. 2012. PMID: 22156668
-
Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study.Int J Cardiol. 2015 Dec 15;201:499-507. doi: 10.1016/j.ijcard.2015.07.080. Epub 2015 Aug 16. Int J Cardiol. 2015. PMID: 26318511 Clinical Trial.
-
Identifying novel biomarkers for cardiovascular disease risk prediction.J Intern Med. 2012 Nov;272(5):430-9. doi: 10.1111/j.1365-2796.2012.02589.x. Epub 2012 Oct 15. J Intern Med. 2012. PMID: 22950687 Review.
-
New directions in cardiovascular risk assessment: the role of secondary risk stratification markers.Int J Clin Pract. 2012 Jul;66(7):622-30. doi: 10.1111/j.1742-1241.2012.02956.x. Int J Clin Pract. 2012. PMID: 22698414 Review.
Cited by
-
Serum immunoglobulin M is associated with the severity of coronary artery disease in adults.PeerJ. 2024 Mar 5;12:e17012. doi: 10.7717/peerj.17012. eCollection 2024. PeerJ. 2024. PMID: 38464758 Free PMC article.
-
Negative work-to-family spillover stress and heightened cardiovascular risk biomarkers in midlife and older adults.J Psychosom Res. 2024 Mar;178:111594. doi: 10.1016/j.jpsychores.2024.111594. Epub 2024 Jan 17. J Psychosom Res. 2024. PMID: 38262325
-
White blood cell and platelet distribution widths are associated with hypertension: data mining approaches.Hypertens Res. 2024 Feb;47(2):515-528. doi: 10.1038/s41440-023-01472-y. Epub 2023 Oct 25. Hypertens Res. 2024. PMID: 37880498
-
Recent Advances in Microbiota-Associated Metabolites in Heart Failure.Biomedicines. 2023 Aug 21;11(8):2313. doi: 10.3390/biomedicines11082313. Biomedicines. 2023. PMID: 37626809 Free PMC article. Review.
-
Association between the accumulation of elevated serum γ-glutamyltransferase level and risk of atrial fibrillation: a nationwide cohort study.Sci Rep. 2023 Aug 23;13(1):13771. doi: 10.1038/s41598-023-40689-2. Sci Rep. 2023. PMID: 37612304 Free PMC article.
References
-
- Gerszten RE, Wang TJ. The search for new cardiovascular biomarkers. Nature. 2008;451:949–952. - PubMed
-
- Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, Ellis SG, Lincoff AM, Topol EJ. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290:898–904. - PubMed
-
- Group. BDW Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69:89–95. - PubMed
-
- Morrow DA, de Lemos JA. Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation. 2007;115:949–952. - PubMed
-
- Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson PW, Sutherland P, Omland T, Vasan RS. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am.J.Cardiol. 2002;90:254–258. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous